Portuguese equine biotech firm Equigerminal has launched what it says is the first-ever commercial diagnostic test for New Equine Virus (NEV), a potentially deadly virus.

NEV was first identified in 2013 by veterinary surgeon Dr Isabel Fidalgo Carvalho…